Two Sigma Securities’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,023
| Closed | -$11.6K | – | 2018 |
|
|
2025
Q1 | $11.6K | Buy |
+1,023
| New | +$11.6K | ﹤0.01% | 1197 |
|
|
2024
Q1 | – | Sell |
-108
| Closed | -$8.45K | – | 2062 |
|
|
2023
Q4 | $8.45K | Buy |
+108
| New | +$8.45K | ﹤0.01% | 1275 |
|
|
2022
Q4 | – | Sell |
-4
| Closed | -$2K | – | 1934 |
|
|
2022
Q3 | $2K | Sell |
4
-1
| -20% | -$500 | ﹤0.01% | 1304 |
|
|
2022
Q2 | $3K | Buy |
5
+1
| +25% | +$600 | ﹤0.01% | 1169 |
|
|
2022
Q1 | $5K | Buy |
+4
| New | +$5K | ﹤0.01% | 1067 |
|
|
2021
Q3 | – | Sell |
-10
| Closed | -$31K | – | 1191 |
|
|
2021
Q2 | $31K | Buy |
+10
| New | +$31K | ﹤0.01% | 639 |
|
|
2019
Q4 | – | Sell |
-7
| Closed | -$119K | – | 1240 |
|
|
2019
Q3 | $119K | Buy |
+7
| New | +$119K | ﹤0.01% | 618 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | -$18K | – | 1298 |
|
|
2019
Q1 | $18K | Buy |
+1
| New | +$18K | ﹤0.01% | 725 |
|
|
2018
Q3 | – | Hold |
0
| – | -$13K | – | 1570 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 991 |
|